Integrity CE

 


 

SABCS 2023 Insights: "KEYNOTE-756 Trial - Pembro vs. Placebo Combined With Neoadjuvant Chemo and Adjuvant ET for High-Risk, Early Stage ER+, HER2- BC"

213 views
January 26, 2024
Comments 0
Login to view comments. Click here to Login